Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV

In recent years, tremendous efforts have been made in the engineering of bispecific or multi-specific antibody-based therapeutics by combining two or more functional antigen-recognizing elements into a single construct. However, to the best of our knowledge there has been no reported cases of effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lili, Xu, Jiyan, Kong, Yu, Liang, Ruiying, Li, Wei, Li, Jinyao, Lu, Jun, Dimitrov, Dimiter S., Yu, Fei, Wu, Yanling, Ying, Tianlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963733/
https://www.ncbi.nlm.nih.gov/pubmed/31690009
http://dx.doi.org/10.3390/antib8040053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963733/
https://www.ncbi.nlm.nih.gov/pubmed/31690009
http://dx.doi.org/10.3390/antib8040053

Ejemplares similares